RhodesAEvansLEAlhazzaniW, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304-377.
2.
RussellJAWalleyKRSingerJ, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358(9):877-887.
3.
LandryDWLevinHRGallantEM, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997;95(5):1122-1125.
4.
JeonKSongJUChungCRYangJHSuhGY. Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS). Crit Care. 2018;22(1):131.
5.
KimHDesaPAvalloneEWeartTAdkinsD.The discontinuation dilemma: which vasopressor should be weaned first in patients recovering from shock?Chest. 2014;146(4):238A.
6.
BauerSRAloiJJAhrensCLYehJYCulverDAReddyAJ.Discontinuation of vasopressin before norepinephrine increases the incidence of hypotension in patients recovering from septic shock: a retrospective cohort study. J Crit Care. 2010;25(2):362.e7-362.e11.
7.
HammondDAMcCainKPainterJT, et al. Discontinuation of vasopressin before norepinephrine in the recovery phase of septic shock. J Intensive Care Med. 2017;34(10):805-810.
8.
MusallamNAltshulerDMerchanCZakharyBAberleCPapadopoulosJ.Evaluating vasopressor discontinuation strategies in patients with septic shock on concomitant norepinephrine and vasopressin infusions. Ann Pharmacother. 2018;52(8):733-739.
9.
SachaGLLamSWDuggalATorbicHReddyAJBauerSR.Hypotension risk based on vasoactive agent discontinuation order in patients in the recovery phase of septic shock. Pharmacotherapy. 2018;38(3):319-326.
10.
BissellBDMageeCMoranPBastinMLTFlanneryAH.Hemodynamic instability secondary to vasopressin withdrawal in septic shock. J Intensive Care Med. 2017;34(9):761-765.
11.
Vasostrict (Vasopressin Injection, USP) [package insert]. In. Vol R2016. Chestnut Ridge, NY: Par Pharmaceutical.
12.
CurtisNCorapiJRobertsRDevlinJW.Rebranding of generic parenteral vasopressin: effect on clinician practices and perceptions. Am J Health Syst Pharm. 2017;74(3):105-106.
13.
SmithSENewsomeASTackettRL.Prescribing of pressor agents in septic shock: a survey of critical care pharmacists. J Pharm Technol. 2019;35(5):187–193.
14.
HammondDARechMADaleyMJ, et al. Perceptions regarding vasopressin use and practices in septic shock, and cost containment strategies. J Am Coll Clin Pharm. 2019; 2(3):257-267.
